Lupin Ltd.

BSE: 500257 | NSE: LUPIN
Mid Cap | Pharmaceuticals & Drugs
2276.80
3.20 (0.14%)
< Home < Back

Lupin’s arm launches post-procedure home-based care guide with ACC

Date: 24-03-2025

Lupin’s wholly owned subsidiary -- Lupin Digital Health (LDH) has launched comprehensive post-procedure home-based care guide at India Live, an annual confluence of leading interventional cardiologists from the Asia Pacific Region, held at Jio World Convention Centre in Mumbai. This guide is based on the American College of Cardiology (ACC)’s ‘Home-Based Care Workbook’ and has been developed by LDH along with the workgroup constituted by the ACC.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.